Freely Filtered 055: STOP ACE!
Freely Filtered, a NephJC Podcast
00:00
I'm Not a Trialist, but It's an Expensive Trial
One of my concerns is patients on 2.5 milligrams of the NASAPRL three times a week, oh, they're in the ACE group, right? Like when you see no difference between these arms and boy, then no different between these arms was pretty extensive no matter how you cut this data. Yeah, so I agree with you. It's a real worry. So far that hasn't come out in the results so far, but it's a problem. If I were to redesign the study, I would put a threshold and say, hey, if we're going to call you on a RAS inhibition, it needs to be call it 20 milligrams daily,
Transcript
Play full episode
